S. Cosgrove

Infectious Diseases · 2003–2017

A researcher in the Science corpus: 11 papers; trusts 3 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

• Infectious Diseases — 35 citations into it
• Critical Care and Intensive Care Medicine — 33 citations into it
• Clinical Biochemistry — 23 citations into it
• Public Health, Environmental and Occupational Health — 21 citations into it; #544 of 2,368 by trust here, #316 by citations
• Applied Microbiology and Biotechnology — 19 citations into it; #26 of 31 by trust here, #19 by citations
• Molecular Medicine — 15 citations into it; #235 of 296 by trust here, #187 by citations
• General Health Professions — 6 citations into it; #4,126 of 4,781 by trust here, #2,452 by citations

Whom S. Cosgrove trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Yehuda Carmeli
2. M. Schwaber
3. T. Dellit
4. Marin Kollef

Who trusts S. Cosgrove overall

1. T. Dellit
2. Emily R. M. Sydnor
3. F. Lowy
4. F. G. Gordillo Altamirano
5. Trish Perl
6. R. Gordon
7. M. Schwaber
8. Yehuda Carmeli
9. J. Siegel
10. D. Levine

Papers from S. Cosgrove's perspective

Ordered by how strongly the researchers S. Cosgrove trusts endorse each paper. Same corpus, a different order for every researcher.

1. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
2. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (Clinical Infectious Diseases)
3. The impact of antimicrobial resistance on health and economic outcomes. (Clinical Infectious Diseases)
4. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. (Clinical Infectious Diseases)
5. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. (Clinical Infectious Diseases)
6. Genome and virulence determinants of high virulence community-acquired MRSA.
7. Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections (Clinical Pharmacokinetics)
8. Segmented regression analysis of interrupted time series studies in medication use research (Journal of Clinical Pharmacy and Therapeutics)
9. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
10. Summary of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

Their papers

• Association of Adverse Events With Antibiotic Use in Hospitalized Patients (2017) — 677 citations
• Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. (2016) — 2,666 citations
• Combination Therapy for Treatment of Infections with Gram-Negative Bacteria (2012) — 727 citations
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. (2011) — 1,585 citations
• An intervention to decrease catheter-related bloodstream infections in the ICU. (2006) — 4,116 citations
• Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. (2006) — 1,346 citations
• The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. (2006) — 1,261 citations
• The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges (2005) — 994 citations
• Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. (2003) — 2,158 citations
• Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (2003) — 1,024 citations
• The impact of antimicrobial resistance on health and economic outcomes. (2003) — 635 citations